CLINICAL_TRIALS
trial_result
· 2025-11-06
Clinical Trial Update: Characterization of Tissue-Specific Immune Responses to Bronchoscopic Instillation of Mycobacterial Antigens Into the Human Lung [EARLY_Phase 1]
Summary
Early Phase 1 study characterizes tissue-specific immune responses to bronchoscopic instillation of mycobacterial antigens in the human lung, including particip…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Healthy, Latent Tuberculosis Infection (LTBI) | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2025-11-06